Case study shows patient on ketogenic diet living fully with IDH1-mutant glioblastoma

(Boston College) Ketogenic metabolic therapy has been shown to successfully starve cancer cells of the glucose and glutamine they need to survive. In a new case study, a British man who rejected the standard of care to treat his glioblastoma has lived for more than 80 months with the typically fatal tumor after adopting a ketogenic diet, researchers report in the journal Frontiers in Nutrition